Related Experiment Videos
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate
Chih-Jung Kuo1, Ya-Hui Chi, John T-A Hsu
1Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan, ROC.
Biochemical and Biophysical Research Communications
|May 19, 2004
Summary
Developing potent anti-SARS drugs is crucial. A new fluorogenic assay enables sensitive detection of SARS main protease activity, facilitating the discovery of effective inhibitors by overcoming previous limitations in enzyme characterization.
Area of Science:
- Biochemistry
- Virology
- Drug Discovery
Background:
- SARS main protease is vital for SARS coronavirus replication.
- Previous assays using HPLC were limited by enzyme dissociation, hindering inhibitor screening.
Purpose of the Study:
- To develop a sensitive assay for characterizing SARS main protease.
- To enable the identification of potent SARS protease inhibitors.
Main Methods:
- A novel fluorogenic peptide substrate with a fluorescence quenching pair (Dabcyl and Edans) was synthesized.
- SARS main protease activity was characterized using the fluorogenic substrate.
- Inhibitor screening was performed under optimized assay conditions.
Main Results:
- The fluorogenic assay provided a highly sensitive signal for protease activity.
- SARS main protease exhibited higher activity (kcat = 1.9 s(-1), Km = 17 microM) compared to previous studies.
- The enzyme remained an active dimer (Kd = 15 nM) under the new assay conditions, unlike its dissociation in older methods.
Conclusions:
- The developed fluorogenic assay is a suitable tool for sensitive characterization of SARS main protease.
- This method overcomes limitations of previous assays, enabling the identification of potent inhibitors.
- This advancement is critical for developing effective anti-SARS therapies.